Published in Cancer Weekly, November 29th, 2005
According to a recent article published in the British Journal of Cancer, "To investigate whether a relationship between chemotherapy-associated adverse events and treatment efficacy exists, we have analyzed the toxicity, objective response and survival data of 303 patients with advanced colorectal cancer. Patients were divided into 2 groups: the first with beneficial effect (I, n=245), and the second with progressive disease (II, n=58)."
"Differences in terms of incidence rates, type and severity of adverse events were analyzed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.